Ss7415 Posted - 6 days ago

$ANVS I feel a deal with $RPRX is a possibility, and wouldn’t be surprised

uberkauft Posted - 2 weeks ago

$RPRX Royalty Pharma plc 14-Day RSI: 45.9 % from 52-Week Low: +10.1% % from 52-Week High: -12.3% Open Interest: 11,883 % Change: 0% Put/Call Ratio: 0.07 % Change: -2.9%

uberkauft Posted - 2 weeks ago

$RPRX Royalty Pharma PLC 14-Day RSI: 54.1 % from 52-Week Low: +12.1% % from 52-Week High: -10.8% Open Interest: 11,910 % Change: 0% Put/Call Ratio: 0.07 % Change: -3.0%

SanKish Posted - 2 weeks ago

$RPRX this thread is dead just like RPRX stock price.

BioAmerica Posted - 09/27/24

$RPRX Great to see RPRX plans coming into effect! From Form 8K file today- "On September 26, 2024, Bristol Myers Squibb (“BMS”) announced that the U.S. Food and Drug Administration (FDA) approved a New Drug Application (NDA) for KarXT (xanomeline-trospium) for the treatment of schizophrenia in adults. BMS intends to market KarXT as Cobenfy. As part of the March 2023 royalty agreement with PureTech Health plc (“PureTech”), Royalty Pharma plc (“Royalty Pharma” or the “Company”) paid $100 million upfront with up to $400 million in additional payments contingent on the achievement of certain regulatory and commercial milestones in exchange for a 3% royalty on sales up to $2 billion annually, after which threshold Royalty Pharma will receive a 1% royalty. Royalty Pharma will pay PureTech a $25 million milestone as a result of this approval." At $2B a year, RPRX gets $60MM/yr. Nice deal. Patience pays off for those who wait.

DonCorleone77 Posted - 09/27/24

$PRTC $BMY $RPRX PureTech Health announces FDA approval of KarXT PureTech Health (PRTC) announced that KarXT, which was initially invented and advanced by PureTech, has received U.S. FDA approval for the treatment of schizophrenia in adults. The FDA approval triggers two separate milestone payments to PureTech totaling $29M under agreements with Royalty Pharma (RPRX) and PureTech's Founded Entity, Karuna Therapeutics, which was acquired by Bristol Myers Squibb (BMY) in March of 2024. Under these agreements, PureTech is also entitled to potential future payments related to additional milestones as well as approximately 2% royalties on net annual sales over $2B. Following the acquisition of Karuna, KarXT is now under the stewardship of BMS and will be marketed as Cobenfy.

Jasooon Posted - 09/26/24

$RPRX approval! Whoohooo https://x.com/adamfeuerstein/status/1839437175773069815?s=46&t=7vIazpOiaR63N_ccf3b54A

UncleStock Posted - 1 month ago

$RPRX $ZTS $JNJ $MRK suggested for $DRG US ARCA Pharmaceutical - value screen: https://zpr.io/tykPs

value420 Posted - 1 month ago

$RPRX look at this trashcan very stinky today

ChemtrailEngineer Posted - 1 month ago

$RPRX

MoEx Posted - 1 month ago

$RPRX hit my RADAR ! Buying time

UncleStock Posted - 1 month ago

$RPRX $JNJ $ZTS $MRK suggested for $DRG US ARCA Pharmaceutical - value screen: https://zpr.io/tykPs

Jasooon Posted - 1 month ago

$RPRX

SanKish Posted - 1 month ago

$RPRX All my dividend and pharma stocks are going up. About time this starts going up.

Stock_Titan Posted - 1 month ago

$RPRX Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement https://www.stocktitan.net/news/RPRX/royalty-pharma-and-ascendis-pharma-enter-into-150-million-royalty-5h8d3m9c57nb.html

Gunslinger28 Posted - 08/30/24

$RPRX its when we don’t fight we die! Don’t let the bears win in this one!

Gunslinger28 Posted - 08/30/24

$RPRX don’t sleep in this stock!!!

Gunslinger28 Posted - 08/30/24

$RPRX let’s get this group poppin!!!

UncleStock Posted - 08/29/24

$RPRX $ZTS $JNJ $OGN suggested for $DRG US ARCA Pharmaceutical - value screen: https://zpr.io/tykPs

insidemoney Posted - 08/28/24

$RPRX Royalty Pharma 14-Day RSI: 64.3 % from 52-Week Low: +13.2% % from 52-Week High: -9.9% Open Interest: 11,806 % Change: 0% Put/Call Ratio: 0.08 % Change: +0.3%

insidemoney Posted - 08/27/24

$RPRX Royalty Pharma 14-Day RSI: 61.5 % from 52-Week Low: +11.9% % from 52-Week High: -10.9% Open Interest: 10,540 % Change: 0% Put/Call Ratio: 0.09 % Change: -0.1%

SanKish Posted - 08/24/24

$RPRX is this finally breaking out or is it still the swing trading dream? May be with cuts, this will break 30-35. One of the stocks which has so much potential in biotech/pharma space.

ALATOM0369 Posted - 08/22/24

$OCGN Good start with smart investors. Let’s recognizing the opportunities in UAE and possible partnership with Opus whom acquired some rights from Iveric Bio “$ISEE”, who got bought out by Astellas “TSE 4503” for $5.9B. Astellas is a subdivision of Royalty Pharma $RPRX .

YungBull100 Posted - 2 months ago

$BLUE they should reach out to $RPRX

JohnDinosaur Posted - 2 months ago

$RPRX BUYYYYYYY!!!!

UncleStock Posted - 2 months ago

$RPRX $JNJ $ZTS $MRK suggested for $DRG US ARCA Pharmaceutical - value screen: https://zpr.io/tykPs

regard2WSB Posted - 2 months ago

$RPRX GS buy rating $51

kinderspiel Posted - 2 months ago

12 Aug volume $LLY 4.21 m $RPRX 4.20 m $MS 4.20 m $EBAY 4.19 m $INFN 4.18 m

366157_38884773 Posted - 2 months ago

$RPRX bizarre stock gets no retail interest

epsguid Posted - 2 months ago

$RPRX reported earnings of $0.96, consensus was $0.95 via @eWhispers #epsbeat http://eps.sh/d/rprx